Logo image of COCH

ENVOY MEDICAL INC (COCH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:COCH - US29415V1098 - Common Stock

0.8419 USD
0 (-0.45%)
Last: 12/5/2025, 8:11:36 PM
0.8569 USD
+0.02 (+1.78%)
Pre-Market: 12/8/2025, 8:16:13 AM
Fundamental Rating

0

Taking everything into account, COCH scores 0 out of 10 in our fundamental rating. COCH was compared to 187 industry peers in the Health Care Equipment & Supplies industry. COCH has a bad profitability rating. Also its financial health evaluation is rather negative. COCH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year COCH has reported negative net income.
In the past year COCH has reported a negative cash flow from operations.
COCH had negative earnings in 4 of the past 5 years.
In the past 5 years COCH always reported negative operating cash flow.
COCH Yearly Net Income VS EBIT VS OCF VS FCFCOCH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

COCH's Return On Assets of -349.72% is on the low side compared to the rest of the industry. COCH is outperformed by 95.72% of its industry peers.
Industry RankSector Rank
ROA -349.72%
ROE N/A
ROIC N/A
ROA(3y)-205.35%
ROA(5y)-123.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COCH Yearly ROA, ROE, ROICCOCH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for COCH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
COCH Yearly Profit, Operating, Gross MarginsCOCH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -2K -4K -6K -8K -10K

More info and screens

0

2. Health

2.1 Basic Checks

COCH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, COCH has more shares outstanding
The debt/assets ratio for COCH is higher compared to a year ago.
COCH Yearly Shares OutstandingCOCH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
COCH Yearly Total Debt VS Total AssetsCOCH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

COCH has an Altman-Z score of -60.07. This is a bad value and indicates that COCH is not financially healthy and even has some risk of bankruptcy.
COCH has a Altman-Z score of -60.07. This is amonst the worse of the industry: COCH underperforms 94.12% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -60.07
ROIC/WACCN/A
WACC6.43%
COCH Yearly LT Debt VS Equity VS FCFCOCH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

COCH has a Current Ratio of 0.64. This is a bad value and indicates that COCH is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of COCH (0.64) is worse than 91.98% of its industry peers.
A Quick Ratio of 0.46 indicates that COCH may have some problems paying its short term obligations.
COCH has a Quick ratio of 0.46. This is amonst the worse of the industry: COCH underperforms 91.98% of its industry peers.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.46
COCH Yearly Current Assets VS Current LiabilitesCOCH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for COCH have decreased by -4.44% in the last year.
COCH shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.18%.
EPS 1Y (TTM)-4.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.11%
Revenue 1Y (TTM)-25.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-25%

3.2 Future

Based on estimates for the next years, COCH will show a small growth in Earnings Per Share. The EPS will grow by 7.35% on average per year.
COCH is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.23% yearly.
EPS Next Y15.96%
EPS Next 2Y7.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-30.66%
Revenue Next 2Y-5.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

COCH Yearly Revenue VS EstimatesCOCH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 100K 200K 300K
COCH Yearly EPS VS EstimatesCOCH Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

COCH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year COCH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COCH Price Earnings VS Forward Price EarningsCOCH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COCH Per share dataCOCH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.35%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for COCH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENVOY MEDICAL INC

NASDAQ:COCH (12/5/2025, 8:11:36 PM)

Premarket: 0.8569 +0.02 (+1.78%)

0.8419

0 (-0.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-10 2025-11-10/bmo
Earnings (Next)03-31 2026-03-31/amc
Inst Owners5.9%
Inst Owner Change-82.21%
Ins Owners37.01%
Ins Owner Change0.07%
Market Cap24.24M
Revenue(TTM)208.00K
Net Income(TTM)-28.61M
Analysts82.5
Price Target8.41 (898.93%)
Short Float %3.58%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP-8.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.36%
Min EPS beat(2)-7.53%
Max EPS beat(2)-1.2%
EPS beat(4)1
Avg EPS beat(4)-7.96%
Min EPS beat(4)-39.48%
Max EPS beat(4)16.38%
EPS beat(8)1
Avg EPS beat(8)-23.26%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-11.76%
Min Revenue beat(2)-41.18%
Max Revenue beat(2)17.65%
Revenue beat(4)1
Avg Revenue beat(4)-26.62%
Min Revenue beat(4)-50.59%
Max Revenue beat(4)17.65%
Revenue beat(8)2
Avg Revenue beat(8)-24.44%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.32%
PT rev (3m)20%
EPS NQ rev (1m)1.54%
EPS NQ rev (3m)3.76%
EPS NY rev (1m)2.77%
EPS NY rev (3m)8.95%
Revenue NQ rev (1m)-21.43%
Revenue NQ rev (3m)-16.98%
Revenue NY rev (1m)-15.6%
Revenue NY rev (3m)-14.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 116.53
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.41
EYN/A
EPS(NY)-1.2
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS0.01
BVpS-0.27
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -349.72%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-205.35%
ROA(5y)-123.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 195.19%
Cap/Sales 253.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.46
Altman-Z -60.07
F-Score2
WACC6.43%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.11%
EPS Next Y15.96%
EPS Next 2Y7.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-25%
Revenue Next Year-30.66%
Revenue Next 2Y-5.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-14.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-136.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-148.72%
OCF growth 3YN/A
OCF growth 5YN/A

ENVOY MEDICAL INC / COCH FAQ

What is the fundamental rating for COCH stock?

ChartMill assigns a fundamental rating of 0 / 10 to COCH.


Can you provide the valuation status for ENVOY MEDICAL INC?

ChartMill assigns a valuation rating of 0 / 10 to ENVOY MEDICAL INC (COCH). This can be considered as Overvalued.


How profitable is ENVOY MEDICAL INC (COCH) stock?

ENVOY MEDICAL INC (COCH) has a profitability rating of 0 / 10.


Is the dividend of ENVOY MEDICAL INC sustainable?

The dividend rating of ENVOY MEDICAL INC (COCH) is 0 / 10 and the dividend payout ratio is -8.51%.